참고문헌
- Abdulkarim BS, Cuartero J, Hanson J, et al (2011). Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol, 29, 2852-8. https://doi.org/10.1200/JCO.2010.33.4714
- Adami HO, Malker B, Holmberg L, et al (1986). The relation between survival and age at diagnosis in breast cancer. N Engl J Med, 315, 559-63. https://doi.org/10.1056/NEJM198608283150906
- Adkins FC, Gonzalez-Angulo AM, Lei X, et al (2011). Triplenegative breast cancer is not a contraindication for breast conservation. Ann Surg Oncol, 18, 3164-73. https://doi.org/10.1245/s10434-011-1920-z
- Bauer KR, Brown M, Cress RD, et al (2007). Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 109, 1721-8. https://doi.org/10.1002/cncr.22618
- Chu QD, Henderson AE, Ampil F, et al (2012). Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity. Int J Breast Cancer, 764570.
- Chung M, Chang HR, Bland KI, et al (1996). Younger women with breast carcinoma have a poorer prognosis than older women. Cancer, 77, 97-103. https://doi.org/10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3
- Dawood S, Broglio K, Kau SW, et al (2009). Triple receptornegative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. J Clin Oncol, 27, 220-6. https://doi.org/10.1200/JCO.2008.17.9952
- Dent R, Trudeau M, Pritchard KI, et al (2007). Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 13, 4429-34. https://doi.org/10.1158/1078-0432.CCR-06-3045
- Fisher B, Anderson S, Bryant J, et al (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347, 1233-41. https://doi.org/10.1056/NEJMoa022152
- Freedman GM, Anderson PR, Li T, et al (2009). Locoregional recurrence of triple-negative breast cancer after breastconserving surgery and radiation. Cancer, 115, 946-51. https://doi.org/10.1002/cncr.24094
- Haffty BG, Yang Q, Reiss M, et al (2006). Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol, 24, 5652-7. https://doi.org/10.1200/JCO.2006.06.5664
- Kwan ML, Kushi LH, Weltzien E, et al (2009). Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res, 11, 31.
- Lowery AJ, Kell MR, Glynn RW, et al (2012). Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat, 133, 831-41. https://doi.org/10.1007/s10549-011-1891-6
- Li CY, Zhang S, Zhang XB, et al (2013). Clinicopathological and prognostic characteristics of triple-negative breast cancer (TNBC) in Chinese patients: a retrospective study. Asian Pac J Cancer Prev, 14, 3779-84. https://doi.org/10.7314/APJCP.2013.14.6.3779
- Ma KK, Chau WW, Wong CHN, et al (2012). Triple negative status is a poor prognostic indicator in Chinese women with breast cancer: a ten year review. Asian Pac J Cancer Prev, 13, 2109-14. https://doi.org/10.7314/APJCP.2012.13.5.2109
- Mersin H, Yildirim E, Berberoglu U, et al (2008). The prognostic importance of triple negative breast carcinoma. Breast, 17, 341-6. https://doi.org/10.1016/j.breast.2007.11.031
- Millar EK, Graham PH, O'Toole SA, et al (2009). Prediction of local recurrence, distant metastases, and death after breastconserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol, 28, 4701-8.
- Nguyen PL, Taghian AG, Katz MS, et al (2008). Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol, 26, 2373-8. https://doi.org/10.1200/JCO.2007.14.4287
- Nielsen TO, Hsu FD, Jensen K, et al (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res, 10, 5367-74. https://doi.org/10.1158/1078-0432.CCR-04-0220
- O'Brien KM, Cole SR, Tse CK, et al (2010). Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res, 16, 6100-10. https://doi.org/10.1158/1078-0432.CCR-10-1533
- Perou CM, Sorlie T, Eisen MB, et al (2000). Molecular portraits of human breast tumours. Nature, 406, 747-52. https://doi.org/10.1038/35021093
- Rakha EA, Reis-Filho JS, Ellis IO (2008). Basal-like breast cancer: a critical review. J Clin Oncol, 26, 2568-81. https://doi.org/10.1200/JCO.2007.13.1748
- Sharif MA, Mamoon N, Mushtaq S, et al (2010). Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan. J Coll Physicians Surg Pak, 20, 181-5.
- Sidoni A, Cavaliere A, Bellezza G, et al (2003). Breast cancer in young women: clinicopathological features and biological specificity. Breast, 12, 247-50. https://doi.org/10.1016/S0960-9776(03)00095-X
- Solin LJ, Hwang WT, Vapiwala N(2009). Outcome after breast conservation treatment with radiation for women with triplenegative early-stage invasive breast carcinoma. Clin Breast Cancer, 9, 96-100. https://doi.org/10.3816/CBC.2009.n.018
- Sorlie T, Perou CM, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74. https://doi.org/10.1073/pnas.191367098
- Spitale A, Mazzola P, Soldini D, et al (2009). Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol, 20,628-35. https://doi.org/10.1093/annonc/mdn675
- Van Dongen JA, Voogd AC, Fentiman IS, et al (2000). Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst, 92, 1143-50. https://doi.org/10.1093/jnci/92.14.1143
- Voduc KD, Cheang MC, Tyldesley S, et al (2010). Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 28, 1684-91. https://doi.org/10.1200/JCO.2009.24.9284
- Wang J, Xie X, Wang X, et al (2013). Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysis. Surg Oncol, 22, 247-55. https://doi.org/10.1016/j.suronc.2013.10.001
- Zaky SS, Lund M, May KA, et al (2011). The negative effect of triple-negative breast cancer on outcome after breastconserving therapy. Ann Surg Oncol, 18, 2858-65. https://doi.org/10.1245/s10434-011-1669-4
피인용 문헌
- Clinicopathology Figures and Long-term Effects of Tamoxifen Plus Radiation on Survival of Women with Invasive Ductal Carcinoma and Triple Negative Breast Cancer vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4863
- High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2698-y
- Breast parenchymal signal enhancement ratio at preoperative magnetic resonance imaging: association with early recurrence in triple-negative breast cancer patients vol.57, pp.7, 2016, https://doi.org/10.1177/0284185115609803
- Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide vol.11, pp.3, 2016, https://doi.org/10.3892/ol.2016.4176
- Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy vol.57, pp.5, 2016, https://doi.org/10.3349/ymj.2016.57.5.1192